Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Kyprolis® (carfilzomib) – New warning
August 4, 2016 – The FDA approved a new update to the Warnings and Precautions section of the Kyprolis (carfilzomib) drug label regarding fatal or serious cases of hemorrhage.
